Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors
Clinical trial NCT03127215 · COMPLETED
Trial details
- NCT number
- NCT03127215
- Sponsor
- National Center for Tumor Diseases, Heidelberg
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2023-12-19
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.